Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

M. C. Minnema; M. S. van der Veer; T. Aarts; M. Emmelot; T. Mutis; H. M. Lokhorst

doi:10.1038/leu.2008.247

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells

M. C. Minnema^*, M. S. van der Veer, T. Aarts, M. Emmelot, T. Mutis, H. M. Lokhorst

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	605-607
Number of pages	3
Journal	Leukemia
Volume	23
Issue number	3
DOIs	https://doi.org/10.1038/leu.2008.247
Publication status	Published - 1 Jan 2009

Access to Document

10.1038/leu.2008.247

Cite this

Minnema, M. C., van der Veer, M. S., Aarts, T., Emmelot, M., Mutis, T., & Lokhorst, H. M. (2009). Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells. Leukemia, 23(3), 605-607. https://doi.org/10.1038/leu.2008.247

@article{0d1f2ddc10db483c9c30fea9c3758c00,

title = "Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells",

author = "Minnema, {M. C.} and {van der Veer}, {M. S.} and T. Aarts and M. Emmelot and T. Mutis and Lokhorst, {H. M.}",

year = "2009",

month = jan,

day = "1",

doi = "10.1038/leu.2008.247",

language = "English",

volume = "23",

pages = "605--607",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

Minnema, MC, van der Veer, MS, Aarts, T, Emmelot, M, Mutis, T & Lokhorst, HM 2009, 'Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells', Leukemia, vol. 23, no. 3, pp. 605-607. https://doi.org/10.1038/leu.2008.247

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells. / Minnema, M. C.; van der Veer, M. S.; Aarts, T. et al.

In: Leukemia, Vol. 23, No. 3, 01.01.2009, p. 605-607.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

AU - Minnema, M. C.

AU - van der Veer, M. S.

AU - Aarts, T.

AU - Emmelot, M.

AU - Mutis, T.

AU - Lokhorst, H. M.

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.scopus.com/inward/record.url?scp=62549095932&partnerID=8YFLogxK

U2 - 10.1038/leu.2008.247

DO - 10.1038/leu.2008.247

M3 - Article

C2 - 18784738

AN - SCOPUS:62549095932

VL - 23

SP - 605

EP - 607

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

Access to Document

Other files and links

Cite this

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells